Portal de Periódicos da CAPES

Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis

2017; Wiley; Volume: 72; Issue: 10 Linguagem: Inglês

10.1111/all.13155

1398-9995

Pascal Demoly, Jörg Kleine‐Tebbe, Dorte Rehm,

Food Allergy and Anaphylaxis Research

Treatment with SQ (standardised quality) house dust mite sublingual tablet for 1 year resulted in a decreased probability of having an allergic rhinitis (AR) exacerbation day (from 11% [placebo] to 5% [SQ house dust mite sublingual tablet]) and an increased probability of having a mild AR day (from 16% [placebo] to 34% [SQ house dust mite sublingual tablet]).